Lymphoplasmacytic Lymphoma Waldenstrom Advanced Management

Personalised therapy by MYD88 and CXCR4 mutation status

Written by: Saygı Hospital Health Guide Editorial Board

Last updated: June 20, 2026

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Hematoloji department. Book Appointment →

What is Lymphoplasmacytic Lymphoma Waldenstrom Advanced Management?

Lymphoplasmacytic lymphoma and Waldenstrom macroglobulinemia represent an indolent B cell non Hodgkin entity defined by lymphoplasmacytic bone marrow infiltration and serum IgM monoclonal gammopathy. The MYD88 L265P mutation is present in over ninety percent of patients and supports the diagnosis when morphology is borderline.

CXCR4 mutations of nonsense or frameshift type appear in roughly one third and predict reduced sensitivity to BTK inhibitors. MYD88 wild type disease tends to follow a more aggressive course and may require alternative regimens including bendamustine combinations or proteasome inhibitor based induction.

Indications for treatment include symptomatic hyperviscosity, hemoglobin under ten, cryoglobulinemia, amyloidosis, peripheral neuropathy, bulky organomegaly and constitutional symptoms. Asymptomatic patients are managed with watchful observation and serial laboratory monitoring without immediate cytoreduction.

Symptoms

Hyperviscosity blurred vision and headache

Anemia related fatigue and pallor

IgM neuropathy with paresthesia

Lymphadenopathy and hepatosplenomegaly

Raynaud and cold agglutinin hemolysis

Risk Factors

Prior IgM MGUS with progression risk

Family history of Waldenstrom

Hepatitis C exposure

Coexisting autoimmune conditions

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

When IgM monoclonal protein is detected
When hyperviscosity symptoms appear
When unexplained neuropathy develops
When anemia or constitutional symptoms emerge

Treatment Methods

Ibrutinib for MYD88 mutant disease

Zanubrutinib with cardiac safety advantage

Bendamustine plus rituximab combination

DRC dexamethasone rituximab cyclophosphamide for neuropathy

Plasmapheresis for symptomatic hyperviscosity

Single agent rituximab for selected frail patients

Which Department to Visit?

You can visit our Hematoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Hematoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book Appointment Contact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.